Attention-deficit hyperactivity disorder (ADHD) is a heritable disorder, prevalent from childhood through adulthood. Although the noradrenergic (NA) system is thought to mediate a portion of the pathophysiology of ADHD, genes in this pathway have not been investigated as frequently as those in the dopaminergic system. Previous association studies of one candidate gene in the NA system, ADRA2A, showed inconsistent results with regard to an MspI polymorphism. In the current study, two nearby single-nucleotide polymorphisms, which define HhaI and DraI restriction fragment length polymorphisms, were also genotyped and were in significant linkage disequilibrium with the MspI RFLP. Transmission disequilibrium tests (TDTs) in a sample of 177 nuclear families showed significant association and linkage of the DraI polymorphism with the ADHD combined subtype (P ¼ 0.03), and the quantitative TDT showed association of this polymorphism with the inattentive (P ¼ 0.003) and hyperactiveimpulsive (P ¼ 0.015) symptom dimensions. The haplotype that contained the less common allele of the DraI polymorphism likewise showed a strong relationship with the inattentive (P ¼ 0.001) and hyperactive-impulsive (P ¼ 0.004) symptom dimensions. This study supports the hypothesis that an allele of the ADRA2A gene is associated and linked with the ADHD combined subtype and suggests that the DraI polymorphism of ADRA2A is linked to a causative polymorphism. Molecular Psychiatry (2005) 10, 572-580.
Attention-deficit hyperactivity disorder (ADHD) is a common and impairing childhood syndrome. 1 The phenotype is characterized by developmentally excessive levels of problems causing impairment in two behavior domains. The domain of inattention-disorganization ('inattention') reflects off task behavior, inability to persist on a task, and distractibility. The domain of hyperactivity-impulsivity ('hyperactivity') reflects excessive motor activity (running about, climbing, interrupting) and impulsive, nonreflective behaviors. Data from twin, adoption, and family studies support substantial heritability for both symptom domains. 2, 3 Willcutt et al 4 examined extreme scores in a twin sample to estimate heritability of the three subtypes of ADHD described in DSM-IV. Heritability was high for the combined subtype (ADHD-C; high inattention and hyperactivity) and for the primarily inattentive type (ADHD-PI), but not the hyperactive type. 4 The present report therefore focuses on ADHD-C and ADHD-PI only.
It is widely thought that ADHD is characterized by multifactorial inheritance. 5 In molecular genetic approaches to ADHD, the most obvious target has been the catecholamine pathway, in part because it is the locus of action of psychostimulants used to treat ADHD. 6 As a result, both dopaminergic (DA) and noradrenergic (NE) systems, which modulate one another, are thought to play roles in shaping the pathophysiology of ADHD. Both systems are expressed in the prefrontal cortex and its many projection regions. Accordingly, a number of prior studies have investigated DA genes with promising, but small, effects for DRD4, DRD5, and DAT1. [7] [8] [9] In contrast, relatively little research has examined NE-relevant genes. NE neurons in the brain are concentrated in the brain-stem nucleus known as the locus coeruleus (LC). They project throughout the brain, providing the only source of NE stimulation to prefrontal cortex and thus key NE-relevant genes are expressed in prefrontal cortex and other brain regions relevant to the development of ADHD. Three types of NE receptors are traditionally recognized, alpha-1, alpha-2, and beta. Animal work suggests that NE projections in the prefrontal cortex enhance prefrontal cortical function-such as working memoryprimarily through postsynaptic alpha-2 receptors. 10 Of the several types of alpha-2 receptors in the brain, the most promising candidate for study is the a-2A adrenergic receptor (ADRA2A). This receptor is expressed in many areas of the brain, but is the most prevalent NE receptor type in the prefrontal cortex.
It is now relatively well established that NE is important to functions of the prefrontal cortex that are implicated as core deficits in ADHD, including working memory, focused attention, and response control. 11 As noted by Berridge, 12 substantial data suggest that NE neurons are important in the regulation of arousal, wakefulness, and signal-to-noise ratio in attention. NE thus supports a key vigilance system in the brain. 13 The importance of NE to vigilance, alertness, and state regulation suggests its involvement in ADHD, because difficulty with arousal and activation are core features of several theories of ADHD [14] [15] [16] and are noted as needing explanation in other theories. 17 As a result, dysfunction of the ascending NE system has often been theorized to mediate ADHD. [18] [19] [20] [21] These theories are supported by substantial behavioral evidence suggesting that arousal and alertness are affected in ADHD. This evidence includes excess slow wave activity on EEG, 22 evidence of impaired signal detection using the d-prime parameter on continuous performance tests, 23 and slow and variable reaction times on fast reaction time tests in children with ADHD. 15, 24, 25 All of these findings are consistent with abnormal functioning of a vigilance/arousal system that is likely mediated by ascending NE neurons, to which ADRA2A plays a key role in the prefrontal cortex.
Recent work implicates NE (as well as dopamine), and ADRA2A in particular, in tasks that reflect executive functioning in animals 10 and humans. 26 These functions, especially working memory, are involved in ADHD. 17 Pharmacological evidence in animals and humans also supports the role of NE, and in particular ADRA2A, in the prefrontal cortex and thus potentially in ADHD. The a-2A agonist clonidine has been used widely in the treatment of ADHD children, 27 suggesting a potential role for the receptor in symptom expression. More definitive evidence emerges from recent work showing that the selective a-2A agonist guanfacine improves function on tasks reliant on prefrontal cortical functions in monkeys 11, 28 and in humans, 26 but does not affect behavior when the prefrontal cortex is not challenged. 11 Thus, pharmacologic investigations point to an important role for the NE system, especially the a-2A receptor, in the cognitive operations of the prefrontal cortex that are suspected of involvement in ADHD.
In short, there is ample evidence to suggest that (a) NE neurons are important in ADHD and its associated multiple cognitive deficits, and (b) at this initial stage of understanding, an important NE receptor in the prefrontal cortex appears to be the a-2A receptor. It is therefore important to evaluate whether polymorphisms of the ADRA2A gene are related to ADHD in order to set the stage for further etiological studies.
Although ADRA2A has only begun to be investigated in relation to ADHD, association between ADHD or its symptoms and one SNP in the ADRA2A gene, rs1800544 (which creates an MspI restriction fragment length polymorphism (RFLP)), has been examined in four published studies. Comings et al 29 examined this association in children with Tourette Syndrome, and found that the additive score of three NE genes correlated with expression of ADHD symptoms. A follow-up report from this sample found that allele m of this SNP in ADRA2A was associated with ADHD symptoms. 30 However, Xu et al 31 failed to find linkage and association with the same polymorphism using a transmission disequilibrium test (TDT) analysis in 94 nuclear families in which the proband had ADHD. Roman et al studied 96 children with ADHD and their parents in a sample from Brazil. Although their HRR analysis with the disorder also yielded nonsignificant effects, this polymorphism was associated with ratings of inattention and hyperactivity, suggesting the possibility of an effect of the gene on symptom expression. 32 Both these results evaluated the G/G (alternatively denoted as m/ m) genotype as the risk genotype. Nonetheless, it is difficult to draw clear conclusions about ADHD and ADRA2A from these few preliminary studies due to conflicting findings and the fact that a sample of Tourette's syndrome patients provide the main positive findings, which may not generalize to other ADHD samples.
The variable results from initial association studies may also be due to the difficulty in detecting minor contributions of a particular candidate gene to the liability for developing ADHD. This limitation is accentuated by restricting the analysis to the examination of a single polymorphism in the gene. If the selected polymorphism is, in fact, the only or primary functional polymorphism that contributes to the disorder being studied, it will then be the most robust marker for the disease. If it is not the functional polymorphism, however, then it would serve merely as a surrogate marker for the causative allele, and yield less robust findings in studies of association and linkage. No evidence suggests that the rs1800544 SNP is functional. Therefore, to address this concern, we chose to examine more closely the haplotype structure of multiple markers in the ADRA2A gene and identify a set of SNPs to study. We used the TDT and quantitative transmission disequilibrium test (QTDT) to assess association and linkage of the ADRA2A gene polymorphisms with ADHD in two of its subtypes and in its two core symptom dimensions.
Materials and methods

Recruitment and diagnosis
Families were recruited from the community using public advertisements and mailings to all parents of children in the second to sixth grades in the local school district. They were excluded from participating if the index child had autism, bipolar disorder, Tourette's syndrome, psychosis, a history of head injury with loss of consciousness, a history of seizures, or a full scale IQ o75 (evaluated with a four-subtest short form of the Wechsler Intelligence Scale for Children, 3rd edn.). 33 Index children were considered as having possible ADHD if they either passed prescreen cutoffs on both parent and teacher versions of common ADHD rating instruments (ie, the Child Behavior Checklist or Teacher Report Form, Behavior Assessment Scale for Children Rating Scale, 34, 35 or a DSM-IV symptoms checklist) 1 or were previously diagnosed as ADHD (any subtype) by a physician or psychologist in the community who utilized teacher and parent ratings to arrive at their diagnosis. Final diagnosis was determined after administration of a structured diagnostic interview, the NIMH Diagnostic Interview Schedule for DSM-IV (DISC-IV), to the primary caregiver (usually the mother). 18 The DISC-IV is a widely used and accepted instrument for evaluating diagnoses in community samples with acceptable reliability and validity. Inter-rater reliability for ADHD diagnosis in our study was k ¼ 1.0, due to the computer-assisted nature of the interview procedure. After administration of the DISC-IV, an 'or' algorithm was employed to identify ADHD. 36 If the child met onset, duration, and impairment criteria, and exceeded the 90th percentile on teacher cutoffs, then a symptom was counted as present if it was endorsed on either the DISC-IV by the parent or by the teacher on the teacher DSM-IV symptom checklist (on the 0-3 scale, a rating of a '2' or '3,' that is 'sometimes' or 'often,' was counted as 'present'). In that way, a final symptom count was arrived at for each child, and they were assigned to the appropriate ADHD subtype. Children who failed to meet our ADHD criteria were retained for quantitative analysis, but were excluded from analysis of the categorical ADHD syndrome. 36 Parents' own childhood symptoms were assessed by structured diagnostic interview using Diagnostic Interview Schedule-IV (DIS-IV; Robins et al, 1995). 37 Parents also completed a DSM-IV symptom checklist in which they rated their symptoms in childhood on a 0-3 scale in the same manner as on the SNAP-IV (Swanson et al., 1998). 38 The DIS-IV used a structured interview format to ask parents to report on their own childhood symptoms of ADHD as well as any symptoms of the disorder during adulthood, and assess impairment, age of onset, and chronicity for DSM-IV criteria. Interviewers were blind to child diagnosis and genotype data.
Due to resource constraints during an earlier period of data collection, 11% of parents did not complete the DIS-IV. For those parents, diagnoses were estimated based on endorsed symptoms (those symptoms rated as a '2' or '3') on the ADHD symptom checklist. Diagnostic agreement between the rating scale and the DIS-IV for assigning ADHD subtypes to parents was considered acceptable (90% agreement, with K ¼ 0.55, Po0.001). Total parent symptom counts were obtained from the DIS-IV or the ADHD-symptom checklist.
For children, comorbid oppositional defiant and conduct disorders were also assessed by the abovenamed rating scales and by the DISC-IV. We noted results for those comorbidities below. Pertinent to the reports by Comings et al, Tourette's syndrome as assessed with the DISC-IV was an exclusion criterion. Transient tic disorders were assessed by the DISC-IV and were present in 9.6% of the sample; covarying their presence did not alter results. Although learning disorders were excluded during most of the study period, five children with learning disorders were allowed in during the final year of data collection. Covarying out learning disorder status also did not alter the results.
Participants and study samples DNA samples were requested from affected children, their biological parents, and siblings when possible. Michigan State University IRB-approved informed consent and assent for minor children were obtained. The majority of the families were Caucasian (82%). The children were aged 7-13 (mean ¼ 9.6), and included both boys and girls (64.5% boys). For TDT analysis, we had complete trios for 51 families of children who met our criteria for either ADHD-C (n ¼ 34) or ADHD-PI (n ¼ 17). Non-ADHD trios (our controls, n ¼ 41, and those cases with borderline ADHD symptom counts, n ¼ 15) were included in the QTDT analyses. For buccal DNA preparation, a modified method described by Meulenbelt was performed, in which cheek swabs were used for sampling, followed by DNA preparation using phenol/chloroform purification (average 60 mg DNA per collection). 39 
Genotyping
The promoter SNP, rs1800544 (MspI RFLP), was typed by a modified amplification of the region using deaza dGTP as described. 31 Briefly, polymerase chain reaction (PCR) was performed in 20 ml containing 40 ng of genomic DNA, 62.5 mM each dATP, dTTP, dCTP, 31.25 mM dGTP, 31.25 mM deaza dGTP, 1 mM of each primer, 1.5 mM MgCl 2 , 1 Â PCR buffer, and 0.5 U of Taq DNA polymerase. For the 5 0 UTR SNP, rs180045 (HhaI RFLP), PCR amplification was performed using primer sets 5 0 -CCAAGTTATCAGGCCACCGA-3 0 and 5 0 -TGCTCCTGGCGGAACATGAA-3 0 in 20 ml volume containing 40 ng of genomic DNA, 200 mM dNTPs, 1 mM of each primer, 1.5 mM MgCl 2 , 1 Â PCR buffer, 2 ml DMSO, and 0.5 U of Taq DNA polymerase. Amplification included an initial denaturing step at 941C for 3 min, followed by 35 cycles consisting of 30 s at 941C, 30 s at 601C, and 45 s at 721C, and the final extension step for 5 min at 721C. After amplification, 10 U of HhaI restriction enzyme was added and digestion was performed at 371C for 2 h. The region for the 3 0 UTR SNP, rs583668 (DraI RFLP), was amplified in 20 ml containing 40 ng of genomic DNA, 200 mM dNTPs, 1 mM of each primer, 1.5 mM MgCl 2 , 1 Â PCR buffer, and 0.5 U of Taq DNA polymerase (primer sets: 5 0 -TACAAGGGCATGGCTCACAA-3 0 and 5 0 -CCAAGGCCAGGATTTCAACA-3 0 ) using the same cycling parameters as above. Digestion of the PCR product was performed with 10 U of DraI restriction enzyme at 371C for 2 h. All restriction fragments were detected using 3% agarose gel stained with ethidium bromide. 40 The quantitative TDT was performed using QTDT software. 41, 42 Owing to the very different distributions in ADHD symptom dimension scores between parents and their offspring, the polygenic variance component (s g 2 ) in the QTDT could not be calculated. This resulted in P-values that were very similar to empirical P-values calculated from 1000 permutations.
Data analysis
Parents of controls were used to determine population haplotype frequencies. Both the use of manual procedures and the expectation maximization (EM) algorithm via maximum likelihood estimation produced the same results for haplotype estimation. For analyses using haplotypes, where phase was ambiguous, the trios were omitted from the analysis (ie, in 13 of 177 family samples). Linkage disequilibrium among the SNPs in ADRA2A was estimated using the GOLD software package. 43 We report findings separately for ADHD-C and ADHD-PI, as well as pooled results for both subtypes, in view of disagreement in the field about the degree of their etiological similarity and whether or not their results should be pooled. 44 Table 1 . We include in Table 1 the frequency information from our own sample in the current study as well. The MspI RFLP is located 5 0 of the transcribed region and the allele frequencies are similar in all Caucasian groups reported. There is a polymorphic SNP in the 5 0 UTR, three nonsynonymous mutations in the coding region, and two 3 0 UTR SNPs. As can be seen in Table 1 , the allele frequencies observed in our sample (labeled 'Michigan' in the table) were typical of those in populations similar to ours as reported in the literature.
Results
SNP selection
We first examined the polymorphic status of the nonsynonymous, coding SNPs, rs18000034, rs1800035, and 1800036, because variants at these positions have the potential to produce functional differences in the protein. We did not find these variants in our population, reinforcing the suspicion that these may be rare mutations. Three polymorphisms were chosen for analysis of the association with ADHD, based on their allele frequencies and their spacing in the genomic region. These were the MspI RFLP (rs1800544) previously studied, a HhaI RFLP (rs1800545) in the 5 0 UTR, and a DraI RFLP (rs553668) in the 3 0 UTR of the ADRA2A mRNA (Figure 1b) .
In this study, participants in 177 families were genotyped for the three SNPs in ADRA2A. For each of the markers, we evaluated Hardy-Weinberg equilibrium by simulation, using 10 000 iterations for each simulation. All of the markers appeared to be in Hardy-Weinberg equilibrium, as their one-tailed P-values were all nonsignificant (ie, MspI P ¼ 0.355, DraI P ¼ 0.343, HhaI P ¼ 0.719).
Transmission disequilibrium testing using individual SNPs
The TDT was conducted to assess association and linkage with each of the three SNPs using the parentoffspring trio data described above. As shown in Table 2 , the TDT revealed a significant association of the DraI RFLP with the ADHD combined subtype (P ¼ 0.033). If both combined and primarily inattentive subtypes are considered together, a P-value of 0.028 was found. The less common allele of the DraI polymorphism was preferentially transmitted to ADHD children. There was no preferential transmission of an allele of HhaI, but transmission of the G allele of the MspI RFLP approached significance in the ADHD-(C þ PI) group.
The composition of our total sample, which contains nondisordered control children, some with intermediate symptom counts, allowed us to use tests such as the QTDT to assess the association of each of the ADRA2A SNPs with the quantitative ADHD symptom dimensions (in addition to the diagnostic categories). We also had similar ADHD symptom data on parents. We included all symptom data (ie, from case and control children as well as parents) in the QTDT analyses in order to make the symptom distribution resemble the population distribution as closely as possible. As shown in Table 3 , both the inattentive and hyperactiveimpulsive symptom scores showed association with the MspI RFLP and even stronger association with the DraI polymorphism. In contrast, neither symptom dimension was associated with the HhaI SNP. When results were repeated excluding parental data, these associations were similar, but fell shy of significance. 
Haplotype analysis
The finding of stronger association of ADHD subtypes and symptom dimensions with the DraI polymorphism than with the MspI RFLP suggests that the former may either be closer to a functional polymorphism or may 'tag' a haplotype that contains the functional polymorphism. Therefore, we determined the relations among the alleles of each of the three SNPs tested in this study. Linkage disequilibrium (ie, LD) was calculated using D 0 and r 2 for each pairwise combination of SNPs (as shown in Figure 1a ). Both D value between the HhaI RFLP and the DraI RFLP was high, r 2 was very low. This is thought to occur when the rare allele at one locus is linked to the common allele at the other locus and vice versa, rather than linkage occurring between alleles of similar frequency. 45 In order to capitalize on the LD among the three SNPs in ADRA2A, we next conducted TDT analyses using multi-marker haplotypes to determine whether this yielded stronger results than tests performed with each SNP alone. These results are summarized in Table 4 . The haplotype containing the rarer alleles of the DraI and MspI RFLPs, and the common allele of the HhaI RFLP (ie, haplotype 212 in Figure 1c ) was preferentially transmitted to children with both subtypes of ADHD. The preferential transmission of haplotype 212 to affected offspring likely drives the marginal significance of haplotype 111, which is less frequently transmitted to affected children. Similar results (summarized in Table 5 ) were obtained using QTDT analyses of linkage and association between the ADHD symptom dimensions and the ADRA2A haplotypes for the entire sample, including both case and control children and parents.
Discussion
The ADRA2A gene may be an important risk factor for ADHD in light of the role of its gene product in attention and the executive functions subserved by the prefrontal cortex and associated circuits thought to be involved in the disorder. 11 Despite its potential relevance, only a handful of studies have investigated the ADRA2A gene as a potential risk factor for the development of ADHD. [29] [30] [31] [32] 46 Those studies analyzed an MspI polymorphism in the promoter of the gene and looked for association with ADHD and/or its symptoms using a variety of statistical approaches. Comings et al found that in Tourette's syndrome patients who also met DSM-IV criteria for ADHD, there was a modest correlation between symptom scores and the MspI polymorphism, but the degree to which that sample represented the complete spectrum of ADHD patients is unclear. There are only two studies of ADHD children without Tourette's syndrome, which yielded inconsistent results. All of these previous studies relied on a single biallelic SNP to test for association between ADHD and ADRA2A, and thus did not adequately sample the array of alleles in this gene, which may lead to Type II errors in assessing the relevance of the gene to the etiology of ADHD. The present report excluded patients with Tourette's syndrome and utilized a strategy of testing multiple SNPs and examining haplotypes. To our knowledge, it is the first study to do so with this gene in relation to ADHD. The positive results reported here therefore provide important new evidence that the ADRA2A gene is involved in the etiology of ADHD, and further clarify that the SNP assessed in prior studies may not be the most important marker in the gene with respect to risk for ADHD.
We chose for study three polymorphic SNPs that span a 3 kb genomic region across the ADRA2A gene. These SNPs are in moderate LD and define one common haplotype (frequency ¼ 0.69), 0.69), in addition to two moderately frequent haplotypes (frequency ¼ 0.18 and 0.11), in our control population (Figure 1c) .
Analyses of the data using the TDT produced significant findings of association and linkage for two of the three SNPs tested. Previous studies implicated the m allele (the rarer G allele) of the MspI marker in the risk for ADHD. 29, 30, 32, 46 We found a trend for association and linkage between the m allele of MspI and ADHD using the TDT (P ¼ 0.13 for ADHD-C and P ¼ 0.086 for ADHD-C þ PI). In contrast, TDT analysis of the DraI RFLP yielded clearly significant results for ADHD-C (P ¼ 0.03) but not for ADHD-PI (P ¼ 0.37), as well as for both subtypes combined (ie, P ¼ 0.028 for ADHD-C þ PI). Despite the identification of ADHD as a categorical disorder in DSM-IV, quantitative genetic analyses suggest that ADHD symptom dimensions show similar genetic influences at all levels of severity. 4 These findings warrant consideration of the association of candidate gene markers with dimensional symptom ratings. We conducted such analyses using the QTDT. 41, 42 This approach revealed significant association and linkage of symptoms of inattention with the rare allele of the MspI polymorphism (P ¼ 0.022) and confirmed association and linkage with the rare allele of DraI (P ¼ 0.003). Similar findings were also obtained with these alleles and the hyperactive-impulsive symptom dimension (P ¼ 0.037 for MspI and P ¼ 0.015 for DraI). The results of the QTDT analyses suggest that the functional risk-inducing allele might reside on chromosomes containing the rare alleles for both DraI and MspI.
The TDT was repeated in order to evaluate association and linkage between ADHD subtypes and symptom dimensions and specific ADRA2A gene haplotypes. The haplotype containing the rare alleles of both the DraI and MspI markers was significantly associated with ADHD and the combined subtype. The QTDT results suggested that the same haplotype was associated with severity on both the inattentive and hyperactive-impulsive symptom dimensions. These results suggest that the rare allele of DraI may be closely linked to a functional polymorphism in the ADRA2A gene.
This study emphasizes several points concerning the search for functional alleles of genes that contribute to the inheritance of complex disorders and diseases. It is clear that marker selection in the candidate gene should not be limited to a single polymorphism. If the HhaI polymorphism had been the only marker selected for analysis, no indication of a significant association between ADHD and the ADRA2A gene would have resulted. In general, it is only when a functional polymorphism is being tested that a single marker will yield the most significant results. When the functional polymorphisms are not known, as is almost always the case, it is prudent to identify several polymorphisms in the candidate gene and to test each for association, both singly and in combination using the haplotypes that they constitute. In the case of ADRA2A, we identified three common haplotypes in the gene, the analyses of which allowed us to better demonstrate association and linkage between the ADHD subtypes and symptom dimensions and ADRA2A.
It is important to be aware that the power of the TDT depends not only on effect size and the mode of inheritance, but also on the allele frequency of the SNP in the population. In the present study, given our sample size, we had adequate power to detect the largest effects in the ranges seen in our data within a multiplicative model for DraI and MspI, but we had much lower power to detect these effects for HhaI, given both its smaller effects and its much greater allele frequency. Furthermore, power was considerably greater for the haplotype analyses than for the analyses of each individual SNP, underscoring the value of incorporating multiple markers in studies of association with candidate genes.
There are several limitations of this study that should be noted. Aside from the relatively small sample, the most important of these is the reliance on parental symptoms in the QTDT analyses. These retrospective symptom ratings are vulnerable to multiple biases, even when obtained in a careful structured interview as in our study. Therefore, the quantitative results should be viewed with some caution until replicated. Nonetheless, we note that in our sample population the QTDT analyses relied only on allelic transmissions from parents and used the parents' symptom scores solely for the purpose of estimating the population mean of the ADHD symptom dimensions.
In conclusion, our results suggest that ADRA2A is associated and linked with ADHD and that the functional polymorphism is closely linked to DraI. Although ambiguous haplotypes were not included, the haplotype TDT and QTDT results suggest that the functional allele is likely to be a less frequent allele (B0.20) and is present on the '212' haplotype, which represents the rare alleles of MspI and DraI and the common allele at HhaI. It is possible that there is more than one functional polymorphism within this haplotype that contributes to the gene's effects. These results underscore the potential importance of NA systems in the etiology of ADHD.
